Jonah J. C. Thomas

Jonah J. C. Thomas

Auto-generated profile, based on publicly available information

Jonah J. C. Thomas

Diabetes Research Centre University of Leicester, College of Life Sciences Leicester UK

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 May 2023 in JMIR Formative Research
Verified
Journal Article
Open access
James  Sanders James Sanders
James Sanders
KGKajal Gokal
Kajal Gokal
JTJonah J C Thomas
Jonah J C Thomas
JRJonathan C Rawstorn
Jonathan C Rawstorn
Lauren SherarLauren Sherar
Lauren Sherar
SISnacktivity Investigators
Snacktivity Investigators
Background: Despite the unequivocal evidence demonstrating the benefits of being physically active, many people do not meet the recommended guidelines of at least 150 minutes of moderate- to vigorous-intensity physical activity per week. This can be changed with the development and implementation of innovative interventions. The use of mobile health (mHealth) technologies has been suggested as a mechanism to offer people innovative health behavior change interventions. Objective: This study aims to outline the systematic, theory-driven processes and user testing applied to the development of a smartphone-based physical activity app (SnackApp) to promote participation in a novel physical activity intervention called Snacktivity. The acceptability of the app was explored and reported. Methods: Intervention mapping involves a 6-step process, the first 4 of which were presented in this study. These steps were used to develop the SnackApp for use within the Snacktivity intervention. The first step involved a needs assessment, which included composing an expert planning group, patient and public involvement group, and gathering the views of the public on Snacktivity and the public perception of the use of wearable technology to support Snacktivity. This first step aimed to determine the overall purpose of the Snacktivity intervention. Steps 2 to 4 involved determining the intervention objectives, the behavior change theory and techniques on which the intervention is based, and the development of the intervention resources (ie, SnackApp). After the completion of steps 1 to 3 of the intervention mapping process, the SnackApp was developed and linked to a commercial physical activity tracker (Fitbit Versa Lite) for the automated capture of physical activity. SnackApp includes provisions for goal setting, activity planning, and social support. Stage 4 involved users (inactive adults, N=15) testing the SnackApp for 28 days. App engagement (mobile app use analytics) was analyzed to determine app use and to inform the further development of SnackApp. Results: Over the study period (step 4), participants engaged with SnackApp an average of 77 (SD 80) times. On average, participants used the SnackApp for 12.6 (SD 47) minutes per week, with most of the time spent on the SnackApp dashboard and engaging, on average, 14 (SD 12.1) times, lasting 7 to 8 minutes per week. Overall, male participants used the SnackApp more than female participants did. The app rating score was 3.5 (SD 0.6) out of 5, suggesting that SnackApp was rated as fair to good. Conclusions: This study outlines and reports data regarding the development of an innovative mHealth app using a systematic, theory-driven framework. This approach can guide the development of future mHealth programs. User testing of the SnackApp suggested that physically inactive adults will engage with the SnackApp, indicating its applicability of use in the Snacktivity physical activity intervention.

19 December 2022 in BMJ
Verified
Journal Article
Open access
PDF file
GBGregory Biddle
Gregory Biddle
James  Sanders James Sanders
James Sanders
KGKajal Gokal
Kajal Gokal
CMClaire Deborah Madigan
Claire Deborah Madigan
JTJonah J C Thomas
Jonah J C Thomas
ADAmanda J Daley
Amanda J Daley
Objectives To examine the recruitment, retention, and preliminary effects of a Christmas themed physical activity intervention designed to increase participation in physical activity and decrease sedentary behaviour in inactive adults. Design Pilot randomised controlled trial. Setting Recruitment from social medial platforms, workplaces, and community groups in the UK. Participants 107 inactive adults (who did not meet the UK guidelines for physical activity) aged 18-75 years. Interventions The intervention consisted of an email sent to participants each day of Advent (1-24 December 2021), which contained a Christmas themed physical activity idea to be completed that day. Each physical activity idea was presented in three intensity formats, including Easy Elf (light intensity), Moderate Mrs Claus (moderate intensity), and Strenuous Santa (vigorous intensity). The comparator group received a leaflet about healthy living on the 1 December. Main outcome measures Participants were randomly assigned (2:1) to either the intervention or control and were masked to group allocation before randomisation. Primary outcomes were recruitment rate, retention, and weekly minutes of participation in self-reported moderate-to-vigorous intensity physical activity by use of the exercise vital signs questionnaire. Primary analysis compared change in minutes of moderate-to-vigorous intensity physical activity from baseline to weeks one, two, and three during the Active Advent intervention. Secondary outcomes were participation in muscle strengthening based physical activity (days per week), accelerometer measured moderate-to-vigorous intensity physical activity, light intensity physical activity, total physical activity, and sedentary time (minutes per day), and enjoyment of and adherence to the intervention. Results 323 individuals expressed interest in participating in the trial and 107 were randomly assigned to the intervention (n=71) or the comparator (n=36) group. The recruitment target (n=105) was reached within 19 days of starting recruitment. 23 (21%) of 107 participants were lost to follow-up. On average, the groups reported participation in similar minutes of moderate-to-vigorous intensity physical activity in weeks one and two. At week three, the adjusted mean difference between groups was 20.6 minutes of participation in moderate-to-vigorous intensity physical activity per week (95% confidence interval −29.7 to 70.9) in favour of the intervention group. Accelerometer data showed that the intervention group spent fewer minutes sedentary per day than comparators (mean difference −58.6 (−113.5 to −3.8)). Overall, 42 (70%) of 60 participants in the intervention group reported that they liked the intervention and 41 (69%) of 59 reported that they completed the Active Advent intervention ideas each day. Conclusions The public were interested to participate in a Christmas themed physical activity intervention during Advent, which might increase physical activity and reduce time sedentary. Enjoyment of, and adherence to the intervention shows the potential benefit that Christmas themed physical activity campaigns/initiatives might have for improving public health. Trial registration ISRCTN12415556.

1 October 2025 in Diabetic Medicine
Verified
Journal Article
Open access
JTJonah J. C. Thomas
Jonah J. C. Thomas
SLStefanie Lanzinger
Stefanie Lanzinger
KSKathrine Kold Soerensen
Kathrine Kold Soerensen
HIHenrik Imberg
Henrik Imberg
SSStefanie Schmid
Stefanie Schmid
PCPratik Choudhary
Pratik Choudhary
Aims: The Real‐world Evidence for Decisions in Diabetes (REDDIE) project aims to better understand how to use real‐world data (RWD) to advance research related to diabetes. To achieve this aim, four national registries (National Diabetes Audit (NDA (England)), Diabetes Patienten Verlaufsdokumentation (DPV (Germany)), Swedish National Registries (NDR), Danish National Registries (DNR)) are contributing data to the REDDIE project. This publication aims to describe the four registries and compare their unique strengths and limitations. Methods: Data regarding the four registries were extracted from their inception until 2024. Data regarding demographics, prescriptions, outcomes, lifestyle and diabetes‐specific variables (usage of continuous glucose monitors) were summarised. Results: A core set of variables was identified across all four registries in the REDDIE project. Demographic information, diabetes‐related medication, measures of glycaemic control and lifestyle factors are measured in all four registries. The DNR, NDA and NDR also contain wider prescription data, diagnosis data (cardiovascular disease, retinopathy) and mortality data. The DPV registry does not contain these data but contains detailed data on continuous glucose monitor and insulin pump usage. Differences in the methodologies employed and data fields collected were identified, including in data collection techniques, linkage processes, follow‐up protocols and the range of variables recorded. Even with this diversity in data collection, there remains a significant opportunity to perform collaborative analysis between the registries. By combining RWD collected in different populations and health care systems with diverse demographics, the transferability of evidence will increase, enabling research studies to be more representative and inclusive of diverse populations. Conclusion: The four registries that make up the REDDIE project contain many commonly collected variables. However, each registry presents specific strengths and limitations. By including all four databases, the REDDIE project benefits from the complementary strengths of each database.

19 July 2023 in Journal of Medical Internet Research
Verified
Journal Article
Open access
JTJonah J C Thomas
Jonah J C Thomas
ADAmanda J Daley
Amanda J Daley
DEDale Esliger
Dale Esliger
VKVictoria E Kettle
Victoria E Kettle
ACApril Coombe
April Coombe
James  Sanders James Sanders
James Sanders
Background: Cardiovascular disease accounts for 17.9 million deaths globally each year. Many research study data sets have been collected to answer questions regarding the relationship between cardiometabolic health and accelerometer-measured physical activity. This scoping review aimed to map the available data sets that have collected accelerometer-measured physical activity and cardiometabolic health markers. These data were then used to inform the development of a publicly available resource, the Global Physical Activity Data set (GPAD) catalogue. Objective: This review aimed to systematically identify data sets that have measured physical activity using accelerometers and cardiometabolic health markers using either an observational or interventional study design. Methods: Databases, trial registries, and gray literature (inception until February 2021; updated search from February 2021 to September 2022) were systematically searched to identify studies that analyzed data sets of physical activity and cardiometabolic health outcomes. To be eligible for inclusion, data sets must have measured physical activity using an accelerometric device in adults aged ≥18 years; a sample size >400 participants (unless recruited participants in a low- and middle-income country where a sample size threshold was reduced to 100); used an observational, longitudinal, or trial-based study design; and collected at least 1 cardiometabolic health marker (unless only body mass was measured). Two reviewers screened the search results to identify eligible studies, and from these, the unique names of each data set were recorded, and characteristics about each data set were extracted from several sources. Results: A total of 17,391 study reports were identified, and after screening, 319 were eligible, with 122 unique data sets in these study reports meeting the review inclusion criteria. Data sets were found in 49 countries across 5 continents, with the most developed in Europe (n=53) and the least in Africa and Oceania (n=4 and n=3, respectively). The most common accelerometric brand and device wear location was Actigraph and the waist, respectively. Height and body mass were the most frequently measured cardiometabolic health markers in the data sets (119/122, 97.5% data sets), followed by blood pressure (82/122, 67.2% data sets). The number of participants in the included data sets ranged from 103,712 to 120. Once the review processes had been completed, the GPAD catalogue was developed to house all the identified data sets. Conclusions: This review identified and mapped the contents of data sets from around the world that have collected potentially harmonizable accelerometer-measured physical activity and cardiometabolic health markers. The GPAD catalogue is a web-based open-source resource developed from the results of this review, which aims to facilitate the harmonization of data sets to produce evidence that will reduce the burden of disease from physical inactivity.

31 March 2026 in Diabetes Research and Clinical Practice
Verified
Journal Article
Open access
AMAisling McCarthy
Aisling McCarthy
NZNatalie Zaremba
Natalie Zaremba
JTJonah Thomas
Jonah Thomas
FPFrançois Pouwer
François Pouwer
PDPatrick Divilly
Patrick Divilly
PCPratik Choudhary
Pratik Choudhary
Meeting the composite target of time in range (TIR) >70% and time below range (TBR) 50% of all participants reported moderate-to-high diabetes distress, highlighting the need for routine screening.

23 January 2026 in Diabetic Medicine
Verified
Journal Article
Open access
AMAisling McCarthy
Aisling McCarthy
JTJonah Thomas
Jonah Thomas
EAEduardo Avila
Eduardo Avila
VKVaios Koutroukas
Vaios Koutroukas
BPBeatrice Pieri
Beatrice Pieri
PDPatrick Divilly
Patrick Divilly
Aims: The mental health impact of impaired awareness of hypoglycaemia (IAH) in people with type 2 diabetes (T2D) is not known. We explored this in people with insulin‐treated T2D and type 1 diabetes (T1D). Methods: Hypo‐METRICS was a 10‐week cross‐sectional observation of hypoglycaemia experience, collecting data on glucose and activity. Participants (325 insulin‐treated T2D, 277 T1D) completed questionnaires scoring depression (PHQ‐9), anxiety (GAD‐7), diabetes distress (PAID) and fear of hypoglycaemia (HFS‐II [worry]) at baseline. IAH was defined as a Gold score ≥4. Relationships between IAH and mental health scores were explored using unadjusted and adjusted generalised linear regression analyses. Age, sex, race, diabetes duration, level of education, employment status, continuous glucose monitoring (CGM) use, hypoglycaemia, use of anti‐depressants and use of anti‐anxiety medications were covariates in the adjusted regression. Results: In unadjusted regression in insulin‐treated T2D, IAH was associated with higher PHQ‐9 (6.4% [1.5%–11.3%]; p = 0.011), GAD‐7 (7.6% [2.1%–13%]; p = 0.006) and HFS‐II (worry) (7.4% [2.8%–12%]; p = 0.002) scores, with no differences in PAID ( p = 0.655). After adjustment, IAH was associated with higher HFS‐II (worry) (5.3% [0.3%–10.6%]; p = 0.048) only. In T1D, IAH was associated with higher PHQ‐9 (6.2% [1.3%–10.8%]; p = 0.012), GAD‐7 (6.1% [0.1%–12.2%]; p = 0.046) and HFS‐II (worry) (6.1% [0.06%–11.5%]; p = 0.029) scores, but not PAID ( p = 0.654), all unadjusted. These relationships remained after adjustment, which also showed higher PAID (8.43% [2.62%–14.24%]; p = 0.005). Conclusion: Our data demonstrated associations between IAH and a greater mental health burden in both insulin‐treated T2D and T1D. Addressing these mental health challenges should be an important part of the holistic care of people with IAH and insulin‐treated diabetes.